Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Aktie von Sharps Technology steigt nach ersten kommerziellen Lieferungen | 1 | Investing.com Deutsch | ||
Mi | Sharps Technology stock soars on first commercial shipments | 4 | Investing.com | ||
Mi | Why Is Sharps Technology Stock Soaring On Wednesday? | 4 | Benzinga.com | ||
Mi | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 304 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
Mi | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Mi | Sharps Technology Inc: Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements | 2 | GlobeNewswire (USA) | ||
22.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
22.05. | Sharps Technology regains compliance with Nasdaq's listing rules | 1 | Seeking Alpha | ||
22.05. | Sharps Technology Inc: Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule | 125 | GlobeNewswire (Europe) | NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
15.05. | Sharps Technology Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
07.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
30.04. | Pre-market Movers: Regulus Therapeutics, Jeffs' Brands, INVO Fertility, GeneDx Holdings, Sharps Technology | 641 | AFX News | TEMPE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regulus Therapeutics Inc. (RGLS) is up over 132%... ► Artikel lesen | |
30.04. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
30.04. | Sharps Technology receives $400K initial purchase order | 1 | Seeking Alpha | ||
24.04. | Sharps Technology announces 1-for-300 reverse stock split; shares down | 6 | Seeking Alpha | ||
24.04. | Sharps Technology Inc: Sharps Technology Announces Reverse Stock Split | 584 | GlobeNewswire (Europe) | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
15.04. | Sharps Technology Inc. - 10-K/A, Annual Report | 3 | SEC Filings | ||
14.04. | Sharps Technology Inc. - 8-K, Current Report | 7 | SEC Filings | ||
04.04. | Sharps Technology Inc. - 8-K, Current Report | 9 | SEC Filings | ||
28.03. | Sharps Technology Inc. - 8-K, Current Report | 8 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
STRATEC | 27,000 | +1,69 % | EQS-News: STRATEC SE: STRATEC mit Zahlen für das erste Quartal 2025 | EQS-News: STRATEC SE
/ Schlagwort(e): Quartalsergebnis
STRATEC MIT ZAHLEN FÜR DAS ERSTE QUARTAL 2025
30.05.2025 / 06:55 CET/CEST
Für... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,783 | +4,54 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
PING AN HEALTHCARE | 0,752 | -3,98 % | PA GOODDOCTOR (01833): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | ||
MOUNTAIN VALLEY MD | 0,012 | -16,44 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,254 | -3,05 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
VERU | 0,525 | -0,94 % | Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave | ||
CYTOSORBENTS | 0,872 | -3,65 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 5,240 | -100,00 % | Tempest Therapeutics-Aktie steigt nach EMA-Orphan-Drug-Designation | ||
VOLITIONRX | 0,589 | 0,00 % | VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., May 15, 2025 /PRNewswire/... ► Artikel lesen | |
EKSO BIONICS | 3,757 | 0,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03485P3001 Anglo American PLC 30.05.2025 US03485P4090 Anglo American PLC 02.06.2025 Tausch 10:8,807339US03815U5083 Applied... ► Artikel lesen | |
IMUNON | 1,330 | +6,40 % | IMNN-001 shows promise in ovarian cancer treatment | ||
BEYOND AIR | 0,161 | 0,00 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
SIEMENS HEALTHINEERS | 46,340 | -0,41 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |